Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
Jan K Buitelaar1, J Antoni Ramos-Quiroga2, Miguel Casas2, J J Sandra Kooij3, Asko Niemelä4, Eric Konofal5, Joachim Dejonckheere6, Bradford H Challis7, Rossella Medori81Department of Psychiatry, University Medical Center, St. Radboud and Karakter Child and Adolescent Psychiatry Universit...
Enregistré dans:
Auteurs principaux: | Jan K Buitelaar, J Antoni Ramos-Quiroga, Miguel Casas, et al |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4949a218c0e4438cbed2e44a68f7c832 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
par: Chou WJ, et autres
Publié: (2018) -
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
par: Rajasree Nair, et autres
Publié: (2009) -
Response to methylphenidate by adult and pediatric patients with attention-deficit/hyperactivity disorder: the Spanish multicenter DIHANA study
par: Valdizán-Usón JR, et autres
Publié: (2013) -
Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
par: Masi G, et autres
Publié: (2019) -
Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment
par: Huss M, et autres
Publié: (2016)